Oral semaglutide: an innovative paradigm in the management of cardiovascular risk in patients with Type 2 diabetes
{{output}}
Cardiovascular (CV) diseases (CVDs) remain a leading global health issue, causing about one-third of all deaths worldwide. Among modifiable CV risk factors (systolic blood pressure, non-HDL cholesterol, diabetes, body mass index, and smoking), diabetes is a le... ...